US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entrada Therapeutics, Inc.

9.13

+0.19002.13%

Post-market: 9.600.4700+5.15%19:51 EDT

Volume:127.38K

Turnover:1.16M

Market Cap:343.24M

PE:5.43

High:9.27

Open:8.77

Low:8.69

Close:8.94

Loading ...

Overview Company News Filings

Entrada Therapeutics Receives Buy Rating Amid Regulatory Progress and Promising Clinical Developments

Optimistic Outlook on Entrada Therapeutics: FDA Lifts Hold on ENTR-601-44, Paving Way for Key Trials

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live

Entrada Therapeutics Inc (TRDA) Receives a Buy from Roth MKM

BUZZ-Entrada rises as FDA removes clinical hold on muscle-wasting therapy

Entrada Therapeutics Says FDA Lifted Clinical Hold on ENTR-601-44; Shares Advance Premarket

MT Newswires Live

Entrada Shares Climb After FDA Removes Hold on Muscular Dystrophy Treatment

Entrada Therapeutics Announces FDA Removal of Clinical Hold on Entr-601-44

THOMSON REUTERS

Entrada Therapeutics Inc - Study Enrollment to Begin in First Half of 2026

THOMSON REUTERS

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

Entrada Therapeutics, Inc. (TRDA): A Cheap Biotech Stock to Invest In Now

Entrada Therapeutics Inc.: Promising Therapeutic Potential and Favorable Valuation Amidst Risks

Entrada Therapeutics Gets UK Approval for Phase 1/2 Study of Duchenne Muscular Dystrophy Treatment

MT Newswires Live

Entrada receives authorization from UK MHRA to initiate ELEVATE-44-201

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate Elevate-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of Entr-601-44 in Patients Living With Duchenne Muscular Dystrophy

THOMSON REUTERS

Entrada Therapeutics Inc - to Initiate Elevate-44-201 Study in Q2 2025

THOMSON REUTERS

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy

Azenta Announces the Election of Dipal Doshi to Its Board of Directors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TRDA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":9.13,"timestamp":1746043200000,"preClose":8.94,"halted":0,"volume":127376,"hourTrading":{"tag":"盘后","latestPrice":9.6,"preClose":9.13,"latestTime":"19:51 EDT","volume":4746,"amount":43916.8118,"timestamp":1746057087686},"delay":0,"floatShares":20987600,"shares":37594630,"eps":1.68,"marketStatus":"Closed","change":0.19,"latestTime":"04-30 16:00:00 EDT","open":8.77,"high":9.27,"low":8.69,"amount":1155683.8491359998,"amplitude":0.064877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.68,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746086400000},"marketStatusCode":5,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":8.94,"postHourTrading":{"tag":"盘后","latestPrice":9.6,"preClose":9.13,"latestTime":"19:51 EDT","volume":4746,"amount":43916.8118,"timestamp":1746057087686},"volumeRatio":1.078392,"impliedVol":1.142,"impliedVolPercentile":0.5522},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","floatShares":20987600,"roa":"5.90%","roe":"19.56%","lyrEps":1.75911,"volumeRatio":1.078392,"shares":37594630,"dividePrice":0,"high":9.27,"amplitude":0.064877,"preClose":8.94,"low":8.69,"week52Low":7.1,"pbRate":"0.80","psRate":"1.63","week52High":21.79,"institutionHeld":0,"latestPrice":9.13,"eps":1.68,"divideRate":0,"volume":127376,"delay":0,"ttmEps":1.68,"open":8.77,"prevYearClose":17.29,"prevWeekClose":8.84,"prevMonthClose":9.04,"prevQuarterClose":9.04,"fiveDayClose":8.71,"twentyDayClose":8.76,"sixtyDayClose":13.33},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRDA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514506798","title":"Entrada Therapeutics Receives Buy Rating Amid Regulatory Progress and Promising Clinical Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2514506798","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514506798?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:16","pubTimestamp":1740482196,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Entrada Therapeutics Inc (TRDA – Research Report), with a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-receives-buy-rating-amid-regulatory-progress-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-receives-buy-rating-amid-regulatory-progress-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA","PRGS","LENZ"],"gpt_icon":0},{"id":"2514744177","title":"Optimistic Outlook on Entrada Therapeutics: FDA Lifts Hold on ENTR-601-44, Paving Way for Key Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2514744177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514744177?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:05","pubTimestamp":1740420309,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has maintained their bullish stance on TRDA stock, giving a Buy rating today. Myles Minter has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-outlook-on-entrada-therapeutics-fda-lifts-hold-on-entr-601-44-paving-way-for-key-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-outlook-on-entrada-therapeutics-fda-lifts-hold-on-entr-601-44-paving-way-for-key-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENTR","TRDA","LENZ","BK4139"],"gpt_icon":0},{"id":"2513733767","title":"BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733767","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513733767?lang=en_us&edition=fundamental","pubTime":"2025-02-24 23:46","pubTimestamp":1740412013,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF15L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AU","TWLO","LU0594300419.USD","BCRX","GFI","LU0823434740.USD","XYZ","AAPL","FDP","CTAS","TRDA","SMCI","ZH","BMRN","LU2750360997.AUD","PDD","TUYA","U","AGIO","LU0198837287.USD","BBWI","YYAI","CEG","LU0345770993.USD","LU1769817179.HKD","HOOD","AXSM","DPZ","MACW.SI","LU1981816686.USD","HE","OC","ARMK","WING","CRL","SMMT","AMRX","NKE","LU2756315318.SGD","PLTR","LU1778281490.HKD","BRDG","IE00B775H168.HKD","LU0823397103.USD","GOOS","PODD","AZUL","IVVD","ABR","SUI"],"gpt_icon":0},{"id":"2513722885","title":"BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722885","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722885?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:25","pubTimestamp":1740407154,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Twilio, Bath & Body Works, WingstopEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL6N3PF0C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS.UK","CTAS","FDP","NVDS","LU1162221912.USD","AMRX","LU0211331839.USD","NVIW.SI","NVD","LU0788109477.HKD","LU2552382058.USD","OC","PODD","2NVD.UK","AGIO","BBWI","NVDU","NVD3.UK","IVVD","IE00B2PGVK34.USD","SG9999001176.USD","LU1718418525.SGD","TRDA","LU2097344357.USD","TWLO","LU1303367103.USD","BRDG","DPZ","AXSM","SNVD.UK","ARMK","LU1923622614.USD","NVDY","AU","NVD2.UK","WING","NVDX","NVDD","ABR","MACW.SI","SMMT","3NVD.UK"],"gpt_icon":1},{"id":"2513724103","title":"Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724103","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724103?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:14","pubTimestamp":1740406493,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher pre-bell Monday, with the iShares Biotechnology ETF  inactive and The Health Care Select Sector SPDR Fund  up 0.3%.Invivyd  shares were down past 28% after the company said the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate COVID-19 in immunocompromised adults and adolescents.Summit Therapeutics  stock was over 5% higher after the company said it will collaborate with Pfizer  on a set of clinical trials to evaluate ivonescimab, its investigational drug, in combination with several Pfizer antibody drug conjugates to treat multiple solid tumors.Entrada Therapeutics  shares were up more than 5% after the company said the US Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and cleared the company's plan to start a phase 1b study of the product candidate as a potential treatment for adults with Duchenne muscular dystrop","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRDA","SG9999001176.SGD","BK4139","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","PFE.AU","XLV","LU0321505439.SGD","LU1057294990.SGD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4568","LU1066053197.SGD","LU1894683264.USD","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","IBB","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","BK4585","LU0306807586.USD","LU2488822045.USD","SMMT","SGXZ57979304.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","BK7095","IVVD","LU1023059063.AUD","SG9999011175.SGD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2513729320","title":"Entrada Therapeutics Inc (TRDA) Receives a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513729320?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:17","pubTimestamp":1740403048,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Entrada Therapeutics Inc (TRDA – Research Report), with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/entrada-therapeutics-inc-trda-receives-a-buy-from-roth-mkm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/entrada-therapeutics-inc-trda-receives-a-buy-from-roth-mkm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2513726825","title":"BUZZ-Entrada rises as FDA removes clinical hold on muscle-wasting therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726825?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:01","pubTimestamp":1740402096,"startTime":"0","endTime":"0","summary":"BUZZ-Entrada rises as FDA removes clinical hold on muscle-wasting therapy** Shares of drug developer Entrada Therapeutics TRDA.O rise 7.4% to $14 premarket** TRDA says FDA has removed clinical hold on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2513253937","title":"Entrada Therapeutics Says FDA Lifted Clinical Hold on ENTR-601-44; Shares Advance Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2513253937","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513253937?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:43","pubTimestamp":1740401006,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics  said Monday that the US Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and cleared the company's plan to start a phase 1b study of the product candidate as a potential treatment for adults with Duchenne muscular dystrophy or DMD.The company said the 1b study is designed to evaluate ENTR-601-44's safety and tolerability in about 32 adults with DMD who are exon-44 skipping amenable.Shares of Entrada Therapeutics were up more than 9% in recent premarket activity Monday.Price: 14.28, Change: +1.24, Percent Change: +9.51","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRDA","ENTR","BK4139","LENZ"],"gpt_icon":0},{"id":"2513872377","title":"Entrada Shares Climb After FDA Removes Hold on Muscular Dystrophy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2513872377","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513872377?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:32","pubTimestamp":1740400320,"startTime":"0","endTime":"0","summary":"Shares of Entrada Therapeutics rose after regulators removed a clinical hold and said its lead product candidate could be studied as a treatment for Duchenne muscular dystrophy.The stock was up 9.5% at 1.28 in premarket trading. Shares had fallen 25% year-to-date when the market closed last week.The clinical-stage biopharma company said Monday that the Food and Drug Administration has lifted a clinical hold on ENTR-601-44 and authorized a Phase 1b clinical study of it as a potential treatment for Duchenne muscular dystrophy in certain adult patients.\"Given the strength of our safety and target engagement data from our Phase 1 clinical study and the profound unmet need in adults living with Duchenne, we are pleased to have obtained FDA clearance,\" Chief Executive Dipal Doshi said.Entrada plans to launch enrollment for the study in the first half of 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Entrada Shares Climb After FDA Removes Hold on Muscular Dystrophy Treatment","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2513740871","title":"Entrada Therapeutics Announces FDA Removal of Clinical Hold on Entr-601-44","url":"https://stock-news.laohu8.com/highlight/detail?id=2513740871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513740871?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUALWLKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2513740655","title":"Entrada Therapeutics Inc - Study Enrollment to Begin in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2513740655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513740655?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUALWLKS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2513146740","title":"Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44","url":"https://stock-news.laohu8.com/highlight/detail?id=2513146740","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513146740?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"– Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy –。– Follows recently received Medicines and Healthcare Products Regulatory Agency authorization in the United Kingdom for ELEVATE-44-201 –。– Expands global ELEVATE-44 clinical program to include pediatric, adult, ambulatory and non-ambulatory patients with Duchenne muscular dystrophy –。BOSTON, Feb. 24, 2025  -- Entrada Therapeutics, Inc.  today announced that the United States Food and Drug Administration  has lifted the clinical hold on ENTR-601-44 and provided authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose  clinical study of ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy  in adult patients with a confirmed mutation in the DMD gene amenable to exon 44 skipping. The global ELEVATE-44 program, which includes the ELEVATE-44-102 study in the U.S. and ELEVATE-44-201 o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/entrada-therapeutics-announces-fda-removal-120000779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PMO","TRDA","BK4139","ENTR","LENZ"],"gpt_icon":0},{"id":"2510337995","title":"Entrada Therapeutics, Inc. (TRDA): A Cheap Biotech Stock to Invest In Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2510337995","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510337995?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:58","pubTimestamp":1739365097,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now.In this article, we are going to take a look at where Entrada Therapeutics, Inc.  stands against the other cheap biotech stocks.Biotech Stocks Face Uncertainty Despite Interest Rate Cuts. Biotechnology stocks are among the most volatile in the market due to their high risk. The outcomes of FDA clinical trials and the effectiveness of their therapies in the real world might cause significant fluctuations in their pricing. The introduction of COVID-19 vaccinations in 2020 caused the biotech industry to soar to prominence. As Big Pharma started investing in acquisitions, investor interest increased in late 2023 and early 2024. But the momentum faded, and for months, biotech stocks did not move. Few M&A transactions and initial public offerings  broke the otherwise quiet period in the second quarter, which saw a steep fall in biopharma deal activity. This slowdown followed a thriving first quarter in which pharmace","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/entrada-therapeutics-inc-trda-cheap-125817130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","BK4139","MNQmain","TSYW.SI","CAGR","USAW.SI","USJW.SI","TQQQ","SQQQ","EEV","QLD","NVIW.SI","BK4159","TRDA",".IXIC","PSQ","NQmain"],"gpt_icon":1},{"id":"2508437808","title":"Entrada Therapeutics Inc.: Promising Therapeutic Potential and Favorable Valuation Amidst Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2508437808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508437808?lang=en_us&edition=fundamental","pubTime":"2025-02-04 19:26","pubTimestamp":1738668376,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Entrada Therapeutics Inc (TRDA – Research Report), with a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-inc-promising-therapeutic-potential-and-favorable-valuation-amidst-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-inc-promising-therapeutic-potential-and-favorable-valuation-amidst-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","TRDA"],"gpt_icon":0},{"id":"2508300128","title":"Entrada Therapeutics Gets UK Approval for Phase 1/2 Study of Duchenne Muscular Dystrophy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2508300128","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508300128?lang=en_us&edition=fundamental","pubTime":"2025-02-04 00:25","pubTimestamp":1738599938,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics  said Monday it has received authorization from UK regulators to start a phase 1/2 multiple ascending dose study of ENTR-601-44 for the potential treatment of certain types of Duchenne muscular dystrophy.The study will consist of two parts, with part A evaluating safety, pharmacokinetics, and pharmacodynamics in about 24 patients using doses from 6 mg/kg to 18 mg/kg every six weeks. Part B will further evaluate the optimal dose established in part A, the company said.The authorization follows the completion of a phase 1 study in which ENTR-601-44 showed a favorable safety profile with no serious adverse events, or changes in trends of vital signs, the company said.The study is expected to begin in Q2, the biopharmaceutical company said.Price: 13.50, Change: +0.06, Percent Change: +0.45","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","TRDA"],"gpt_icon":0},{"id":"2508112312","title":"Entrada receives authorization from UK MHRA to initiate ELEVATE-44-201","url":"https://stock-news.laohu8.com/highlight/detail?id=2508112312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508112312?lang=en_us&edition=fundamental","pubTime":"2025-02-03 20:05","pubTimestamp":1738584332,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics (TRDA) announced it had received authorization from the United Kingdom’s Medicines and Healthcare Products Regulatory Agency, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/entrada-receives-authorization-from-uk-mhra-to-initiate-elevate-44-201?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/entrada-receives-authorization-from-uk-mhra-to-initiate-elevate-44-201?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2508782114","title":"Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate Elevate-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of Entr-601-44 in Patients Living With Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2508782114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508782114?lang=en_us&edition=fundamental","pubTime":"2025-02-03 20:00","pubTimestamp":1738584001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250203:nTUA4FFVZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2508114757","title":"Entrada Therapeutics Inc - to Initiate Elevate-44-201 Study in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508114757?lang=en_us&edition=fundamental","pubTime":"2025-02-03 20:00","pubTimestamp":1738584001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250203:nTUA4FFVZ9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2508128121","title":"Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2508128121","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508128121?lang=en_us&edition=fundamental","pubTime":"2025-02-03 20:00","pubTimestamp":1738584000,"startTime":"0","endTime":"0","summary":"– Company on track to initiate ELEVATE-44-201 in Q2 2025 – – ENTR-601-44 regulatory filings submitted in additional geographies including the U.S. and EU, with regulatory discussions ongoing – BOSTON,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/03/3019369/0/en/Entrada-Therapeutics-Receives-Authorization-in-the-United-Kingdom-to-Initiate-ELEVATE-44-201-a-Phase-1-2-Multiple-Ascending-Dose-Clinical-Study-of-ENTR-601-44-in-Patients-Living-wi.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMO","UBCP","LENZ","ENTR","BK4211","TRDA","BK4139"],"gpt_icon":0},{"id":"2507608210","title":"Azenta Announces the Election of Dipal Doshi to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2507608210","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507608210?lang=en_us&edition=fundamental","pubTime":"2025-01-31 05:05","pubTimestamp":1738271107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA7TBNLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B66KJ199.SGD","LU2065732104.USD","LU0012050646.USD","TRDA","AZTA","IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU0106261612.USD","LU1169590202.USD","IE0031619046.USD","BK4121","BK4147","BK4139","LU1169589451.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"TRDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-11-05","symbol":"TRDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-08-13","symbol":"TRDA","fiscalQuarterEnding":"2024/06","expectedEps":0.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":1.55},{"market":"US","date":"2024-05-07","symbol":"TRDA","fiscalQuarterEnding":"2024/03","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":0.68},{"market":"US","date":"2024-03-13","symbol":"TRDA","fiscalQuarterEnding":"2023/12","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1733457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRDA","date":"2025-04-29","current":4.815239,"percent":0.757042,"low":-69.405148,"twenty":-10.961909,"median":-5.502472,"eighty":5.557476,"high":25.975557,"avg":-6.372253,"sd":16.456836,"marketCap":316004890},"quantilePoints":[{"date":"2021-10-29","current":-7.394936,"twenty":-17.597525,"median":-17.597525,"eighty":-11.475972,"marketCap":251013723},{"date":"2021-11-05","current":-21.790051,"twenty":-21.952046,"median":-20.803996,"eighty":-17.597525,"marketCap":739641498},{"date":"2021-11-12","current":-28.525158,"twenty":-25.58108,"median":-21.983741,"eighty":-18.485692,"marketCap":968257962},{"date":"2021-11-19","current":-28.868516,"twenty":-29.41789,"median":-24.54132,"eighty":-20.606786,"marketCap":979912918},{"date":"2021-11-26","current":-25.452541,"twenty":-28.824496,"median":-24.607351,"eighty":-21.353369,"marketCap":863961039},{"date":"2021-12-03","current":-23.533255,"twenty":-28.623764,"median":-25.505365,"eighty":-21.812942,"marketCap":798812818},{"date":"2021-12-10","current":-15.265518,"twenty":-28.187082,"median":-23.647708,"eighty":-19.069596,"marketCap":631748205},{"date":"2021-12-17","current":-11.577357,"twenty":-26.820692,"median":-22.432748,"eighty":-16.202556,"marketCap":479117339},{"date":"2021-12-23","current":-12.836913,"twenty":-26.764346,"median":-21.904504,"eighty":-14.360448,"marketCap":531242809},{"date":"2021-12-31","current":-12.912336,"twenty":-26.676305,"median":-20.53107,"eighty":-13.447835,"marketCap":534364094},{"date":"2022-01-07","current":-8.930026,"twenty":-26.218494,"median":-18.937535,"eighty":-12.769033,"marketCap":369560215},{"date":"2022-01-14","current":-6.516506,"twenty":-25.584602,"median":-17.597525,"eighty":-11.577357,"marketCap":269679075},{"date":"2022-01-21","current":-6.101682,"twenty":-25.577558,"median":-15.559666,"eighty":-10.093042,"marketCap":252512005},{"date":"2022-01-28","current":-7.021837,"twenty":-25.519451,"median":-14.360448,"eighty":-7.766209,"marketCap":290591689},{"date":"2022-02-04","current":-7.715724,"twenty":-25.463106,"median":-13.5308,"eighty":-7.379146,"marketCap":319307516},{"date":"2022-02-11","current":-8.537829,"twenty":-24.100237,"median":-13.16123,"eighty":-7.512789,"marketCap":353329529},{"date":"2022-02-18","current":-11.275667,"twenty":-23.579036,"median":-12.802973,"eighty":-7.548286,"marketCap":466632197},{"date":"2022-02-25","current":-9.126125,"twenty":-23.517408,"median":-12.086459,"eighty":-7.649352,"marketCap":377675557},{"date":"2022-03-04","current":-7.813773,"twenty":-22.862386,"median":-11.577357,"eighty":-7.720249,"marketCap":323365188},{"date":"2022-03-11","current":-6.388288,"twenty":-22.163344,"median":-11.204016,"eighty":-7.720249,"marketCap":264372890},{"date":"2022-03-18","current":-6.017184,"twenty":-21.936199,"median":-10.78542,"eighty":-7.363356,"marketCap":307827117},{"date":"2022-03-25","current":-6.255428,"twenty":-21.835832,"median":-10.117931,"eighty":-6.952448,"marketCap":320015196},{"date":"2022-04-01","current":-5.638438,"twenty":-21.46254,"median":-9.64654,"eighty":-6.638691,"marketCap":288451197},{"date":"2022-04-08","current":-4.502198,"twenty":-20.388445,"median":-9.144981,"eighty":-6.309439,"marketCap":230323437},{"date":"2022-04-14","current":-4.948141,"twenty":-19.729901,"median":-9.028075,"eighty":-6.17703,"marketCap":253137020},{"date":"2022-04-22","current":-4.107655,"twenty":-19.333718,"median":-8.726386,"eighty":-6.029276,"marketCap":210139396},{"date":"2022-04-29","current":-3.666235,"twenty":-18.754411,"median":-8.454865,"eighty":-5.912113,"marketCap":187557252},{"date":"2022-05-06","current":-3.457787,"twenty":-18.126844,"median":-8.349273,"eighty":-5.760614,"marketCap":176893461},{"date":"2022-05-13","current":-2.854496,"twenty":-17.597525,"median":-7.941992,"eighty":-5.364762,"marketCap":183969409},{"date":"2022-05-20","current":-2.883329,"twenty":-16.900041,"median":-7.813773,"eighty":-4.563286,"marketCap":185827686},{"date":"2022-05-27","current":-3.373495,"twenty":-15.618496,"median":-7.753435,"eighty":-4.36536,"marketCap":217418392},{"date":"2022-06-03","current":-3.200495,"twenty":-15.214231,"median":-7.632759,"eighty":-4.157927,"marketCap":206268731},{"date":"2022-06-10","current":-4.55566,"twenty":-14.879355,"median":-7.394936,"eighty":-4.140761,"marketCap":293607743},{"date":"2022-06-17","current":-4.11355,"twenty":-14.259382,"median":-7.131199,"eighty":-4.140761,"marketCap":265114165},{"date":"2022-06-24","current":-4.714243,"twenty":-13.855117,"median":-6.935101,"eighty":-4.15057,"marketCap":303828266},{"date":"2022-07-01","current":-5.766658,"twenty":-13.576054,"median":-6.811331,"eighty":-4.187355,"marketCap":371655372},{"date":"2022-07-08","current":-5.656131,"twenty":-13.503648,"median":-6.516506,"eighty":-4.216733,"marketCap":364531977},{"date":"2022-07-15","current":-5.209215,"twenty":-13.455377,"median":-6.350577,"eighty":-4.227922,"marketCap":335728686},{"date":"2022-07-22","current":-5.233243,"twenty":-13.218551,"median":-6.255428,"eighty":-4.255794,"marketCap":337277250},{"date":"2022-07-29","current":-6.151102,"twenty":-12.962115,"median":-6.178897,"eighty":-4.266149,"marketCap":396432396},{"date":"2022-08-05","current":-5.21402,"twenty":-12.851998,"median":-6.151102,"eighty":-4.298784,"marketCap":336038398},{"date":"2022-08-12","current":-5.083828,"twenty":-12.782609,"median":-6.05057,"eighty":-4.359782,"marketCap":395150717},{"date":"2022-08-19","current":-5.22471,"twenty":-12.238059,"median":-6.026259,"eighty":-4.396116,"marketCap":406101054},{"date":"2022-08-26","current":-5.860692,"twenty":-12.075145,"median":-5.963285,"eighty":-4.405727,"marketCap":455534002},{"date":"2022-09-02","current":-5.309239,"twenty":-11.675406,"median":-5.919443,"eighty":-4.443999,"marketCap":412671256},{"date":"2022-09-09","current":-6.005599,"twenty":-11.577357,"median":-5.919443,"eighty":-4.466633,"marketCap":466797205},{"date":"2022-09-16","current":-5.599054,"twenty":-11.396343,"median":-5.874796,"eighty":-4.487556,"marketCap":435197663},{"date":"2022-09-23","current":-6.074028,"twenty":-11.266616,"median":-5.860692,"eighty":-4.499555,"marketCap":472115940},{"date":"2022-09-30","current":-6.343716,"twenty":-11.192702,"median":-5.898062,"eighty":-4.525626,"marketCap":493078013},{"date":"2022-10-07","current":-5.961322,"twenty":-11.10672,"median":-5.888899,"eighty":-4.547138,"marketCap":463355671},{"date":"2022-10-14","current":-6.243086,"twenty":-10.903079,"median":-5.892909,"eighty":-4.553823,"marketCap":485256344},{"date":"2022-10-21","current":-7.587503,"twenty":-10.513899,"median":-5.919443,"eighty":-4.571231,"marketCap":589753842},{"date":"2022-10-28","current":-9.117079,"twenty":-10.255954,"median":-5.957297,"eighty":-4.615058,"marketCap":708643211},{"date":"2022-11-04","current":-8.909464,"twenty":-10.100584,"median":-5.973297,"eighty":-4.663727,"marketCap":692505938},{"date":"2022-11-11","current":-6.743676,"twenty":-9.96784,"median":-6.011392,"eighty":-4.695302,"marketCap":596370284},{"date":"2022-11-18","current":-6.332606,"twenty":-9.758166,"median":-6.033802,"eighty":-4.710399,"marketCap":560017708},{"date":"2022-11-25","current":-5.226969,"twenty":-9.516814,"median":-6.017184,"eighty":-4.72039,"marketCap":462241813},{"date":"2022-12-02","current":-6.488529,"twenty":-9.262707,"median":-6.011392,"eighty":-4.755372,"marketCap":573806616},{"date":"2022-12-09","current":-6.757851,"twenty":-9.16356,"median":-6.033802,"eighty":-4.809238,"marketCap":597623821},{"date":"2022-12-16","current":-7.505574,"twenty":-9.145735,"median":-6.049635,"eighty":-4.867597,"marketCap":663747905},{"date":"2022-12-23","current":-5.304931,"twenty":-9.135788,"median":-6.033802,"eighty":-4.931786,"marketCap":469136267},{"date":"2022-12-30","current":-4.791093,"twenty":-9.127349,"median":-6.017184,"eighty":-4.849836,"marketCap":423695546},{"date":"2023-01-06","current":-5.04624,"twenty":-9.126125,"median":-6.001574,"eighty":-4.798181,"marketCap":446259214},{"date":"2023-01-13","current":-4.858424,"twenty":-9.117079,"median":-5.963335,"eighty":-4.832074,"marketCap":429649847},{"date":"2023-01-20","current":-4.737938,"twenty":-9.004373,"median":-5.936357,"eighty":-4.79343,"marketCap":418994782},{"date":"2023-01-27","current":-4.273712,"twenty":-8.93926,"median":-5.907226,"eighty":-4.785423,"marketCap":377941441},{"date":"2023-02-03","current":-5.10294,"twenty":-8.913576,"median":-5.876808,"eighty":-4.726537,"marketCap":451273363},{"date":"2023-02-10","current":-5.73372,"twenty":-8.859542,"median":-5.853158,"eighty":-4.736273,"marketCap":507055765},{"date":"2023-02-17","current":-3.919341,"twenty":-8.845264,"median":-5.829192,"eighty":-4.699967,"marketCap":346603013},{"date":"2023-02-24","current":-3.926429,"twenty":-8.842391,"median":-5.815955,"eighty":-4.628083,"marketCap":347229782},{"date":"2023-03-03","current":-3.766962,"twenty":-8.772142,"median":-5.776163,"eighty":-4.547138,"marketCap":333127489},{"date":"2023-03-10","current":-4.254453,"twenty":-8.615439,"median":-5.76082,"eighty":-4.499555,"marketCap":402539289},{"date":"2023-03-17","current":-5.429059,"twenty":-8.539287,"median":-5.747436,"eighty":-4.511816,"marketCap":513675855},{"date":"2023-03-24","current":-5.271746,"twenty":-8.488051,"median":-5.734949,"eighty":-4.524607,"marketCap":498791493},{"date":"2023-03-31","current":-5.068986,"twenty":-8.454865,"median":-5.728214,"eighty":-4.53629,"marketCap":479607205},{"date":"2023-04-06","current":-4.883706,"twenty":-8.451848,"median":-5.696978,"eighty":-4.543209,"marketCap":462076735},{"date":"2023-04-14","current":-5.932462,"twenty":-8.421679,"median":-5.680564,"eighty":-4.551986,"marketCap":561305812},{"date":"2023-04-21","current":-5.257762,"twenty":-8.349273,"median":-5.670547,"eighty":-4.55566,"marketCap":497468439},{"date":"2023-04-28","current":-4.805367,"twenty":-8.340215,"median":-5.658534,"eighty":-4.562088,"marketCap":454664626},{"date":"2023-05-05","current":-4.191543,"twenty":-8.062667,"median":-5.64652,"eighty":-4.528859,"marketCap":396587028},{"date":"2023-05-12","current":-5.064425,"twenty":-7.979703,"median":-5.633268,"eighty":-4.502198,"marketCap":403224467},{"date":"2023-05-19","current":-5.277006,"twenty":-7.913544,"median":-5.617686,"eighty":-4.518228,"marketCap":420149939},{"date":"2023-05-26","current":-4.970025,"twenty":-7.90428,"median":-5.592298,"eighty":-4.528859,"marketCap":395708454},{"date":"2023-06-02","current":-4.76989,"twenty":-7.868078,"median":-5.581432,"eighty":-4.538767,"marketCap":379773885},{"date":"2023-06-09","current":-6.116634,"twenty":-7.822824,"median":-5.586978,"eighty":-4.549103,"marketCap":487000254},{"date":"2023-06-16","current":-6.016566,"twenty":-7.801706,"median":-5.597041,"eighty":-4.554742,"marketCap":479032969},{"date":"2023-06-23","current":-6.667006,"twenty":-7.789638,"median":-5.618244,"eighty":-4.559517,"marketCap":530820317},{"date":"2023-06-30","current":-6.279244,"twenty":-7.759469,"median":-5.62503,"eighty":-4.565397,"marketCap":499947091},{"date":"2023-07-07","current":-6.658667,"twenty":-7.721758,"median":-5.636859,"eighty":-4.57261,"marketCap":530156377},{"date":"2023-07-14","current":-6.737887,"twenty":-7.69008,"median":-5.655758,"eighty":-4.584244,"marketCap":536463810},{"date":"2023-07-21","current":-7.325784,"twenty":-7.579961,"median":-5.662109,"eighty":-4.599308,"marketCap":583271606},{"date":"2023-07-28","current":-6.971378,"twenty":-7.548286,"median":-5.680564,"eighty":-4.620996,"marketCap":555054140},{"date":"2023-08-04","current":-6.024905,"twenty":-7.53565,"median":-5.7162,"eighty":-4.635607,"marketCap":479696910},{"date":"2023-08-11","current":-6.317571,"twenty":-7.508508,"median":-5.728214,"eighty":-4.646146,"marketCap":520365665},{"date":"2023-08-18","current":-6.081084,"twenty":-7.503806,"median":-5.74007,"eighty":-4.685973,"marketCap":500886743},{"date":"2023-08-25","current":-6.565311,"twenty":-7.485744,"median":-5.747894,"eighty":-4.706554,"marketCap":540771554},{"date":"2023-09-01","current":-5.939851,"twenty":-7.432417,"median":-5.767385,"eighty":-4.717317,"marketCap":489253674},{"date":"2023-09-08","current":-5.90757,"twenty":-7.394936,"median":-5.767385,"eighty":-4.729611,"marketCap":486594686},{"date":"2023-09-15","current":-6.125472,"twenty":-7.334123,"median":-5.776163,"eighty":-4.737938,"marketCap":504542851},{"date":"2023-09-22","current":-5.491941,"twenty":-7.325784,"median":-5.777303,"eighty":-4.750864,"marketCap":452360224},{"date":"2023-09-29","current":-6.528994,"twenty":-7.315985,"median":-5.798618,"eighty":-4.757855,"marketCap":537780193},{"date":"2023-10-06","current":-5.891429,"twenty":-7.305739,"median":-5.815592,"eighty":-4.762744,"marketCap":485265193},{"date":"2023-10-13","current":-5.245793,"twenty":-7.264602,"median":-5.81239,"eighty":-4.76989,"marketCap":432085446},{"date":"2023-10-20","current":-5.911605,"twenty":-7.242394,"median":-5.819157,"eighty":-4.778229,"marketCap":486927060},{"date":"2023-10-27","current":-5.61098,"twenty":-7.227384,"median":-5.819157,"eighty":-4.783375,"marketCap":462165240},{"date":"2023-11-03","current":-6.323198,"twenty":-7.199866,"median":-5.83392,"eighty":-4.792261,"marketCap":520829149},{"date":"2023-11-10","current":-24.667435,"twenty":-7.289284,"median":-5.845821,"eighty":-4.795681,"marketCap":537010063},{"date":"2023-11-17","current":-23.534356,"twenty":-7.370611,"median":-5.860692,"eighty":-4.801055,"marketCap":512342934},{"date":"2023-11-24","current":-17.593348,"twenty":-7.503806,"median":-5.888899,"eighty":-4.80845,"marketCap":383007177},{"date":"2023-12-01","current":-19.859506,"twenty":-7.579961,"median":-5.902072,"eighty":-4.82304,"marketCap":432341435},{"date":"2023-12-08","current":-20.456669,"twenty":-7.795672,"median":-5.911605,"eighty":-4.834509,"marketCap":445341678},{"date":"2023-12-15","current":-21.421317,"twenty":-7.911691,"median":-5.925612,"eighty":-4.846375,"marketCap":466342072},{"date":"2023-12-22","current":-22.600332,"twenty":-8.347461,"median":-5.932462,"eighty":-4.855589,"marketCap":492009220},{"date":"2023-12-29","current":-25.126791,"twenty":-8.454865,"median":-5.939851,"eighty":-4.857715,"marketCap":547010250},{"date":"2024-01-05","current":-21.5285,"twenty":-8.540017,"median":-5.941515,"eighty":-4.868537,"marketCap":468675449},{"date":"2024-01-12","current":-24.698059,"twenty":-8.846163,"median":-5.963335,"eighty":-4.891549,"marketCap":537676742},{"date":"2024-01-19","current":-22.952505,"twenty":-8.966963,"median":-5.978768,"eighty":-4.905676,"marketCap":499676030},{"date":"2024-01-26","current":-22.814698,"twenty":-9.138499,"median":-5.992309,"eighty":-4.915832,"marketCap":496675974},{"date":"2024-02-02","current":-22.615644,"twenty":-9.581677,"median":-6.004236,"eighty":-4.91911,"marketCap":492342559},{"date":"2024-02-09","current":-22.217535,"twenty":-10.307241,"median":-6.016566,"eighty":-4.921856,"marketCap":483675730},{"date":"2024-02-16","current":-22.99844,"twenty":-11.237955,"median":-6.024748,"eighty":-4.926434,"marketCap":500676049},{"date":"2024-02-23","current":-20.272926,"twenty":-11.577357,"median":-6.028302,"eighty":-4.929152,"marketCap":441341603},{"date":"2024-03-01","current":-20.257614,"twenty":-12.836913,"median":-6.037413,"eighty":-4.93164,"marketCap":441008264},{"date":"2024-03-08","current":-19.262342,"twenty":-13.485547,"median":-6.058862,"eighty":-4.948141,"marketCap":419341191},{"date":"2024-03-15","current":-61.321385,"twenty":-15.009082,"median":-6.081084,"eighty":-4.952685,"marketCap":409933456},{"date":"2024-03-22","current":-65.487505,"twenty":-17.593348,"median":-6.089351,"eighty":-4.961191,"marketCap":437783972},{"date":"2024-03-28","current":-69.405148,"twenty":-18.101359,"median":-6.099956,"eighty":-4.961191,"marketCap":463973412},{"date":"2024-04-05","current":-66.890118,"twenty":-18.959167,"median":-6.113366,"eighty":-4.968258,"marketCap":447160438},{"date":"2024-04-12","current":-64.133258,"twenty":-19.427711,"median":-6.12749,"eighty":-4.972184,"marketCap":428730832},{"date":"2024-04-19","current":-57.740708,"twenty":-19.862568,"median":-6.151102,"eighty":-4.983342,"marketCap":385996632},{"date":"2024-04-26","current":-59.922347,"twenty":-20.184117,"median":-6.16971,"eighty":-4.990199,"marketCap":400580888},{"date":"2024-05-03","current":-65.74005,"twenty":-20.444419,"median":-6.184272,"eighty":-4.992718,"marketCap":439472236},{"date":"2024-05-10","current":19.415556,"twenty":-20.444419,"median":-6.175043,"eighty":-4.972184,"marketCap":455974329},{"date":"2024-05-17","current":20.21327,"twenty":-20.380109,"median":-6.165519,"eighty":-4.951776,"marketCap":474708650},{"date":"2024-05-24","current":20.307914,"twenty":-20.2913,"median":-6.137664,"eighty":-4.92478,"marketCap":476931366},{"date":"2024-05-31","current":21.13267,"twenty":-20.263739,"median":-6.121053,"eighty":-4.910399,"marketCap":496300749},{"date":"2024-06-07","current":21.36252,"twenty":-20.202491,"median":-6.101682,"eighty":-4.850628,"marketCap":501698774},{"date":"2024-06-14","current":22.241358,"twenty":-20.073872,"median":-6.099956,"eighty":-4.811533,"marketCap":522338281},{"date":"2024-06-21","current":19.523721,"twenty":-19.926878,"median":-6.084547,"eighty":-4.791677,"marketCap":458514576},{"date":"2024-06-28","current":21.190193,"twenty":-19.908503,"median":-6.084547,"eighty":-4.774893,"marketCap":497651675},{"date":"2024-07-05","current":21.220101,"twenty":-19.884004,"median":-6.074028,"eighty":-4.75366,"marketCap":498354077},{"date":"2024-07-12","current":25.975557,"twenty":-19.868693,"median":-6.049635,"eighty":-4.708476,"marketCap":610035963},{"date":"2024-07-15","current":25.646563,"twenty":-19.86563,"median":-6.041344,"eighty":-4.695302,"marketCap":602309543},{"date":"2024-08-02","current":23.867006,"twenty":-19.862568,"median":-6.039378,"eighty":-4.672517,"marketCap":560516636},{"date":"2024-08-09","current":21.608912,"twenty":-19.826255,"median":-6.030346,"eighty":-4.59214,"marketCap":507485300},{"date":"2024-08-16","current":5.477968,"twenty":-19.64186,"median":-6.024748,"eighty":-4.554742,"marketCap":572140896},{"date":"2024-08-23","current":5.427433,"twenty":-19.500935,"median":-6.016566,"eighty":-4.515022,"marketCap":566862843},{"date":"2024-08-30","current":5.895722,"twenty":-19.427711,"median":-6.004236,"eighty":-4.471291,"marketCap":615772797},{"date":"2024-09-06","current":5.184866,"twenty":-19.32359,"median":-5.996942,"eighty":-4.404766,"marketCap":541528191},{"date":"2024-09-13","current":5.00631,"twenty":-19.188845,"median":-5.984239,"eighty":-4.33112,"marketCap":522879072},{"date":"2024-09-20","current":5.053476,"twenty":-19.038789,"median":-5.963335,"eighty":-4.288277,"marketCap":527805255},{"date":"2024-09-27","current":5.312888,"twenty":-18.96223,"median":-5.941515,"eighty":-4.265242,"marketCap":554899258},{"date":"2024-10-04","current":5.53861,"twenty":-18.944963,"median":-5.936157,"eighty":-4.226961,"marketCap":578474559},{"date":"2024-10-11","current":5.326364,"twenty":-18.856806,"median":-5.931781,"eighty":-4.189868,"marketCap":556306738},{"date":"2024-10-18","current":5.939519,"twenty":-18.609029,"median":-5.915524,"eighty":-4.126724,"marketCap":620347109},{"date":"2024-10-25","current":5.673369,"twenty":-18.19595,"median":-5.907226,"eighty":-4.100192,"marketCap":592549366},{"date":"2024-10-31","current":5.80476,"twenty":-17.843071,"median":-5.891429,"eighty":-4.019982,"marketCap":606272302},{"date":"2024-11-08","current":12.390042,"twenty":-17.597525,"median":-5.862704,"eighty":-3.976074,"marketCap":680845207},{"date":"2024-11-15","current":12.267624,"twenty":-17.595854,"median":-5.851076,"eighty":-3.881511,"marketCap":674118187},{"date":"2024-11-22","current":11.629759,"twenty":-17.593348,"median":-5.835599,"eighty":-3.819187,"marketCap":639066874},{"date":"2024-11-29","current":12.815285,"twenty":-17.245441,"median":-5.821992,"eighty":-3.767275,"marketCap":704212749},{"date":"2024-12-06","current":13.092338,"twenty":-15.736155,"median":-5.81239,"eighty":-3.495412,"marketCap":719437057},{"date":"2024-12-13","current":11.67486,"twenty":-15.214231,"median":-5.797942,"eighty":-3.367358,"marketCap":641545250},{"date":"2024-12-20","current":11.133642,"twenty":-14.879355,"median":-5.778442,"eighty":-3.167818,"marketCap":611804741},{"date":"2024-12-27","current":11.430023,"twenty":-14.360448,"median":-5.768112,"eighty":-2.950607,"marketCap":628091210},{"date":"2025-01-03","current":11.249617,"twenty":-13.956183,"median":-5.754982,"eighty":-2.907357,"marketCap":618177707},{"date":"2025-01-10","current":10.450675,"twenty":-13.687679,"median":-5.750196,"eighty":-2.871796,"marketCap":574275052},{"date":"2025-01-17","current":8.079622,"twenty":-13.52175,"median":-5.745698,"eighty":4.66739,"marketCap":443983302},{"date":"2025-01-24","current":8.324459,"twenty":-13.470462,"median":-5.734949,"eighty":4.930845,"marketCap":457437341},{"date":"2025-01-31","current":8.614397,"twenty":-13.333193,"median":-5.728214,"eighty":5.00631,"marketCap":473369756},{"date":"2025-02-07","current":8.685271,"twenty":-13.061672,"median":-5.704997,"eighty":5.067626,"marketCap":477264347},{"date":"2025-02-14","current":8.13761,"twenty":-12.882167,"median":-5.680564,"eighty":5.23877,"marketCap":447169785},{"date":"2025-02-21","current":8.421105,"twenty":-12.823337,"median":-5.663281,"eighty":5.326364,"marketCap":462748146},{"date":"2025-02-28","current":6.463236,"twenty":-12.636289,"median":-5.655945,"eighty":5.420021,"marketCap":424156296},{"date":"2025-03-07","current":5.656685,"twenty":-12.097773,"median":-5.638438,"eighty":5.496161,"marketCap":371225587},{"date":"2025-03-14","current":5.873832,"twenty":-11.969554,"median":-5.62503,"eighty":5.544674,"marketCap":385476089},{"date":"2025-03-21","current":5.651256,"twenty":-11.577357,"median":-5.617686,"eighty":5.571626,"marketCap":370869324},{"date":"2025-03-28","current":5.406965,"twenty":-11.517019,"median":-5.599973,"eighty":5.615422,"marketCap":354837509},{"date":"2025-04-04","current":4.353801,"twenty":-11.27265,"median":-5.589567,"eighty":5.571626,"marketCap":285722573},{"date":"2025-04-11","current":4.261514,"twenty":-11.237955,"median":-5.571525,"eighty":5.568257,"marketCap":279666109},{"date":"2025-04-17","current":4.266943,"twenty":-11.147449,"median":-5.559289,"eighty":5.565562,"marketCap":280022372},{"date":"2025-04-25","current":4.864097,"twenty":-11.079568,"median":-5.509464,"eighty":5.565562,"marketCap":319211253},{"date":"2025-04-29","current":4.815239,"twenty":-10.961909,"median":-5.502472,"eighty":5.557476,"marketCap":316004890}],"updateTime":1746035876016}}}